DOCSLIB.ORG

Scientific Programme for All

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Programme for All Optimal radiotherapy Scientific Programme for all ESTRO ANNUAL CONFE RENCE 27 - 31 August 2021 Onsite in Madrid, Spain & Online Saturday 28 August 2021 Track: Radiobiology Teaching lecture: The microbiome: Its role in cancer development and treatment response Saturday, 28 August 2021 08:00 - 08:40 N104 Chair: Marc Vooijs - 08:00 The microbiome: Its role in cancer development and treatment response SP - 0004 A. Facciabene (USA) Track: Clinical Teaching lecture: Breast reconstruction and radiotherapy Saturday, 28 August 2021 08:00 - 08:40 Plenary Chair: Philip Poortmans - 08:00 Breast reconstruction and radiotherapy SP - 0005 O. Kaidar-Person (Israel) Track: Clinical Teaching lecture: Neurocognitive changes following radiotherapy for primary brain tumours Saturday, 28 August 2021 08:00 - 08:40 Room 1 Chair: Brigitta G. Baumert - 08:00 Evaluation and care of neurocognitive effects after radiotherapy SP - 0006 M. Klein (The Netherlands) 08:20 Imaging biomarkers of dose-induced damage to critical memory regions SP - 0007 A. Laprie (France Track: Physics Teaching lecture: Independent dose calculation and pre-treatment patient specific QA Saturday, 28 August 2021 08:00 - 08:40 Room 2.1 Chair: Kari Tanderup - 08:00 Independent dose calculation and pre-treatment patient specific QA SP - 0008 P. Carrasco de Fez (Spain) 1 Track: Physics Teaching lecture: Diffusion MRI: How to get started Saturday, 28 August 2021 08:00 - 08:40 Room 2.2 Chair: Tufve Nyholm - Chair: Jan Lagendijk - 08:00 Diffusion MRI: How to get started SP - 0009 R. Tijssen (The Netherlands) Track: RTT Teaching lecture: The role of RTT leadership in advancing multi-disciplinary research Saturday, 28 August 2021 08:00 - 08:40 N103 Chair: Sophie Perryck - 08:00 The role of RTT leadership in advancing multi-disciplinary research SP - 0010 M. Velec (Canada) Track: Brachytherapy Teaching lecture: New developments In skin cancers treatment: is brachytherapy the new frontier especially for the face? Saturday, 28 August 2021 08:00 - 08:40 N105-N106 Chair: Luca Tagliaferri - 08:00 New developments In skin cancers treatment: is brachytherapy the new frontier SP - 0011 especially for the face? P. Wojcieszek (Poland) Track: Interdisciplinary Symposium: Education in radiation oncology Saturday, 28 August 2021 08:45 - 10:00 N101-102 Chair: Jesper Grau Eriksen & TBC - 08:45 ESTRO Curricula done and published - Now what? SP - 0012 M. Giuliani (Canada) 2 09:03 How to design a training programme that actually train the resident SP - 0013 B. Millar (Canada) 09:21 Does work-place based assessment deliver on its promise? SP - 0014 S. Turner (Australia) 09:39 The trainee perspective - What do we really need for good training? SP - 0015 J. Heukelom (The Netherlands) Track: Radiobiology Joint symposium: ESTRO-EACR: How does cancer cell metabolism affect the radiation response and vice versa? Saturday, 28 August 2021 08:45 - 10:00 N104 Chair: Caroline Dive - Chair: Anthony Chalmers - 08:48 Tumour metabolic adaptations as biomarkers for radiation oncology SP - 0016 O. Maddocks (United Kingdom) 09:06 Application of metabolic imaging for the predication and assessment of treatment SP - 0017 response J. Bussink (The Netherlands) 09:24 Radiation-driven tumour metabolic reprogramming SP - 0018 T. Burns (UK) 09:42 Targeting tumour metabolism for enhancing radiotherapy response SP - 0019 L. Kunz-Schughart (Germany Track: Clinical Symposium: New endpoints for early breast cancer - Less is more? Saturday, 28 August 2021 08:45 - 10:00 Plenary Chair: Elisabetta Bonzano - Chair: Dorota Gabrys - 08:45 Health-related quality of life - Primary or surrogate endpoint? SP - 0020 I. Meattini (Italy) 3 09:03 Less surgery or less radiation therapy in early stage breast cancer? SP - 0021 P. Poortmans (Belgium) 09:21 Tumour bed boost in breast cancer - When, whom, how? SP - 0022 M. Krause (Germany) 09:39 Less endocrine therapy for very low-risk patients? SP - 0023 E. Nowicka (Poland) Track: Clinical Symposium: Radiosurgery for central nervous system disorders: Beyond glioblastoma and metastases Saturday, 28 August 2021 08:45 - 10:00 Room 1 Chair: Sławomir Blamek - Chair: Maximilian Niyazi - 08:45 Radiotherapy for vestibular schwannoma and meningioma SP - 0024 E. Herrmann (Switzerland) 09:03 SRS for Parkinson's disease and trigeminal neuralgia - in memoriam Leszek SP - 0025 Miszczyk L. Miszczyk (Poland), G. Głowacki, A. Roch-Zniszczoł, D. Larysz, M. Stąpór-Fudzińska, B. Goc, S. Blamek, A. Rożek 09:21 Primary and repeat radiosurgery for functioning and nonfunctioning pituitary SP - 0026 adenoma G. Minniti (Italy) 09:39 Can we treat epilepsy and obsessive-compulsive disorder with radiation? SP - 0027 Sameer Sheth (USA) Track: Physics Symposium: Clinical implementation of in vivo dosimetry Saturday, 28 August 2021 08:45 - 10:00 Room 2.1 Chair: Elise Konradsson - Chair: Cristina Garibaldi - 4 08:45 Large scale clinical implementation of in vivo dosimetry - What value does it SP - 0028 bring? E. Bossuyt (Belgium) 09:10 In vivo dosimetry in EBRT: Requirements and future directions for research, SP - 0029 development, and clinical practice I. Olaciregui Ruiz (The Netherlands) 09:35 In vivo dosimetry in brachytherapy: Requirements and future directions for SP - 0030 research, development and clinical practice K. Tanderup (Denmark), G. Fonseca, J.G. Johansen, R. Smith, L. Beaulieu, S. Beddar, G. Kertzscher, F. Verhaegen Track: Physics Symposium: The use of MR in radiotherapy Saturday, 28 August 2021 08:45 - 10:00 Room 2.2 Chair: Marielle Philippens, Uulke van der Heide & Emilia Persson - 08:45 Does MR-only treatment planning live up to its expectations? SP - 0147 T. Nyholm (Sweden) 09:10 Real-time adaptation under MR-guidance SP - 0148 J. Bertholet (Switzerland) 09:35 A roadmap for imaging biomarker studies on MR-linac systems SP - 0149 P. van Houdt (The Netherlands) Track: RTT Symposium: RTT-led radiomics research Saturday, 28 August 2021 08:45 - 10:00 N103 Chair: Ingrid Kristensen - Chair: Sophie Perryck - 08:45 Personalised breast cancer treatment using radiomics SP - 0035 W. Tran (Canada) 5 09:10 MR radiomics in prostate cancer SP - 0036 M. Leech (Ireland) 09:35 Head and neck radiomics in a toxicity prediction model SP - 0037 A. Duffton (United Kingdom), W. Nailon, T. Berger, D. Noble, C. Paterson Track: Brachytherapy Debate: Prostate cancer: Short treatments by SBRT or brachytherapy? Saturday, 28 August 2021 08:45 - 10:00 N105-N106 Chair: Barbara Jereczek-Fossa - Chair: Carl Salembier - 08:45 SBRT SP - 0038 G. Marvaso (Italy) 09:10 Brachy SP - 0039 P. Hoskin (United Kingdom) 09:35 Rebuttals + Discussion SP - 0040 Track: Physics Poster highlights: Poster Highlights 1: Treatment planning 1 Saturday, 28 August 2021 08:45 - 09:45 Online Stream 1 Chair: Christopher Kurz - 08:45 Introducing a probabilistic target presence in expected-value optimization PH - 0041 G. Buti (Belgium), K. Souris, A.M. Barragan-Montero, J.A. Lee, E. Sterpin 08:53 Dosimetric impact of auto segmentation on treatment planning in IMRT for PH - 0042 prostate patients M. Kawula (Germany), D. Purice, M. Li, G. Vivar, S. Ahmadi, K. Parodi, C. Belka, G. Landry, C. Kurz 6 09:01 Robustness of Wide Tangents and VMAT through simulations and CBCT PH - 0043 delivered dose in breast cancer I. Gleeson (United Kingdom), M. Toomey, K. Hutchinson, H. Chantler 09:09 Robust planning of VMAT for breast cancer including loco-regional lymph nodes PH - 0044 M. Kjeldsen (Denmark) 09:17 Comparing robustness of margin and robustly optimised plans to anatomical PH - 0045 deformations in H&N J. Robbins (United Kingdom), E. Vasquez Osorio, A. Green, M. van Herk 09:25 Benefit of 4D robustly optimized proton plans for NSCLC patients with PH - 0046 intrafractional motion > 5mm S. Spautz (Germany), L. Haase, M. Tschiche, S. Makocki, E.G. Troost, C. Richter, K. Stützer 09:33 CTV and OAR robustness of clinical neuro IMPT: dosimetric impact of the PH - 0047 DUPROTON robustness protocol J. Rojo Santiago (The Netherlands), S.J. Habraken, D. Lathouwers, A. Méndez Romero, Z. Perkó, M.S. Hoogeman Track: Clinical Poster highlights: Poster Highlights 2: Head and neck 1 Saturday, 28 August 2021 08:45 - 09:45 Online Stream 2 Chair: Pierluigi Bonomo - 08:45 Pattern of failure after curative (C-)RT in HNSCC: data from the phase III PH - 0048 DAHANCA19 study M.H. Kristensen (Denmark), C.R. Hansen, R. Zukauskaite, A.I.S. Holm, E.S. Hinsby, C. Maare, J. Johansen, H. Primdahl, Å. Bratland, C.A. Christensen, M. Andersen, J. Overgaard, J.G. Eriksen 08:53 Reduction of GTV to CTV radiation margin in head and neck squamous cell PH - 0049 carcinoma is oncological safe and significantly reduced acute and late radiation- related toxicity A. Al-Mamgani (The Netherlands), R. Kessels, A. Navran, O. Hamming-Vrieze, C.L. Zuur, J.P. de Boer, M.C. Jonker, T. Janssen, J. Sonke, C.A. Marijnen 09:01 Detailed analysis of lymphatic progression patterns for oropharyngeal squamous PH - 0050 cell carcinoma B. Pouymayou (Switzerland), J. Hoffmann, R. Ludwig, M. Guckenberger, P. Balermpas, J. Unkelbach 7 09:09 Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two PH - 0051 population-based cohorts P. Lassen (Denmark), S.H. Huang, J. Su, B. O'Sullivan, J. Waldron, M. Andersen, H. Primdahl, J. Johansen, C. Andrup Kristensen, E. Andersen, J. Eriksen, C. Rønn Hansen, J. Alsner, J. Lilja-Fisher, S. V. Bratman, J. Ringash, J. Kim, A. Hope, A. Spreafico, J. de Almeida, W. Xu, J. Overgaard 09:17 Do head and neck cancer patients in randomized trials represent the population PH - 0052 in daily practice? J. Kaanders (The Netherlands), S. van den Bosch, J. Kleijnen 09:25 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in PH - 0053 advanced cancers: phase I trial C. Shen (USA), J. Frakes, J. Niu, A. Rosenberg, J. Weiss, J. Caudell, K. Jameson, P. Said, T. Seiwert 09:33 Re-Irradiation in head & neck cancer - a pooled analysis of 253 individual cases PH - 0054 J.
Load more

Recommended publications
  • Electrochemotherapy
    Service: Cancer Services Electrochemotherapy Exceptional healthcare, personally delivered What to expect from your treatment You have been told by your doctor that you need electrochemotherapy to treat the cancer that has either spread from your original cancer and /or is suitable for this treatment. This leaflet is designed to answer your questions about the treatment so that you are fully aware of what to expect. What is Electrochemotherapy? Electrochemotherapy is a treatment combining a low dose of a chemotherapy drug (Bleomycin) and an electrical pulse (electroporation) applied directly to the cancer cells using an electrode. This low level dose of chemotherapy drug is not normally effective against the cancer, as it is difficult to get inside the cells. When the electric pulse is applied, the cells form pores allowing the drug to enter and be active against the cancer. What happens to the normal cells? As the chemotherapy drug is most active against the cancer cells, the normal tissue is unaffected. 2 Electrochemotherapy What type of cancer can be treated? Electrochemotherapy is used to treat cancers that have spread to the skin or just below the skin’s surface (metastasised) from the following types of cancer: n All skin cancer (melanoma & non-melanoma) n Breast cancer recurrence n Head and neck cancer, including oral cancer Electrochemotherapy has the advantage of preserving healthy tissue when compared to other treatment options. It can also be used to shrink large cancers making them easier to remove surgically. What happens during the treatment? The chemotherapy drug is usually given into a vein and after a short time a probe is inserted into the cancer, which releases a small electrical current.
    [Show full text]
  • Rough Cilicia Archaeological Survey Project: Analysis of Amphora Finds Season 2000 Summer Elizabeth L
    Purdue University Purdue e-Pubs Rough Cilicia Archaeological Survey Project, School of Languages and Cultures 1996-2011 4-9-2018 Rough Cilicia Archaeological Survey Project: Analysis of Amphora Finds Season 2000 Summer Elizabeth L. Will University of Massachusetts Amherst Follow this and additional works at: https://docs.lib.purdue.edu/rcas Part of the Classical Archaeology and Art History Commons Recommended Citation Will, Elizabeth L., "Rough Cilicia Archaeological Survey Project: Analysis of Amphora Finds Season 2000 Summer" (2018). Rough Cilicia Archaeological Survey Project, 1996-2011. Paper 6. http://dx.doi.org/10.5703/1288284316718 This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact [email protected] for additional information. Rough Cilicia Archaeological Survey Project: Analysis of Amphora Finds Season 2000 Summer Elizabeth Lyding Will, University of Massachusetts Amherst During a visit to the RCSP headquarters at Gazipaşa in September, 2000, I analyzed the Study Collection of amphora fragments amassed since 1996, as well as 49 bags of additional fragments, seven of them collected during the surveys of the year 2000. I also visited three areas that had been identified as the sites of possible kilns, at Biçkici, Syedra, and Antiocheia ad Cragum. In addition, I examined and photographed the amphoras on display in the museums at Alanya and Antalya.1 The amphora fragments collected during the 1996-1999 seasons have been noted in the reports for those years. They have also been described by Nicholas Rauh and Kathleen Slane in the article, “Possible amphora kiln sites in W. Rough Cilicia.” 2 About the 1996-1999 finds I have only a few observations of my own to add.
    [Show full text]
  • Enhancing Healthcare Decision-Making Process: Findings from Orthopaedic Field
    administrative sciences Article Enhancing Healthcare Decision-Making Process: Findings from Orthopaedic Field Irene Schettini * , Gabriele Palozzi and Antonio Chirico Department of Management and Law, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] (G.P.); [email protected] (A.C.) * Correspondence: [email protected]; Tel.: +39-0672-595-401 Received: 29 October 2020; Accepted: 20 November 2020; Published: 25 November 2020 Abstract: In the healthcare field, the decision-making process is part of the broad spectrum of “clinical reasoning”, which is recognised as the whole process by which a physician decides about patients’ treatments and cares. Several clinicians’ intrinsic variables lead to this decisional path. Little is known about the inference of these variables in triggering biases in decisions about the post-discharge period in the surgical field. Accordingly, this research aims to understand if and how cognitive biases can affect orthopaedists in decision-making regarding the follow-up after knee and hip arthroplasty. To achieve this goal, an interview-based explorative case study was run. Three key-decisional orthopaedic surgeons were interviewed through a quality control tool aimed at monitoring the causes and effects of cognitive distortions. Coherently with the literature, eight biases come to light. All the interviewees agree on the presence of four common biases in orthopaedic surgery (Affect heuristic, Anchoring, Halo effect, Saliency). The other biases (Groupthink, Availability, Overconfidence, Confirmation), instead, depending on specific physicians’ intrinsic variables; namely: (i) working experience; (ii) working context. This finding contributes to the debate about the application of cognitive tools as leverage for improving the quality of clinical decision-making process and, indirectly, enhancing better healthcare outcomes.
    [Show full text]
  • Manoscritti Tonini
    Manoscritti Tonini strumento di corredo al fondo documentario a cura di Maria Cecilia Antoni Biblioteca Civica Gambalunga. Rimini. 2013 1 Il Fondo Tonini entrò in biblioteca nel 1924, in agosto una prima parte: più di 1500 fra volumi e opuscoli e dieci buste di manoscritti...e tutti i manoscritti, codici e pergamene appartenuti ai Tonini, custoditi dai fratelli Ricci,1 il resto in dicembre, in una stanza al piano terra di palazzo Gambalunga; il 26 aprile 1925 viene trasmessa al Sindaco di Rimini una Relazione degli esecutori testamentari: Alessandro Tosi e padre Gregorio Giovanardi2. La relazione, dattiloscritta, intitolata: Elenco manoscritti, opuscoli, libri di Luigi e Carlo Tonini, donati alla Biblioteca Gambalunga descrive nove nuclei contrassegnati da lettere alfabetiche (A-I) e da capoversi, interni ai nuclei, numerati progressivamente da 1 a 733; i nuclei A-F sono preceduti dal titolo: Luigi Tonini 4; il nucleo G è invece intitolato: Manoscritti di Carlo Tonini 5; seguono H: Pergamene (nn.47-53); I: Raccolta di documenti riguardanti la storia di Rimini ed altri luoghi, originali ed in copia. Questa descrizione tuttavia non permetteva più il rinvenimento dei documenti a causa di interventi, spostamenti e condizionamenti successivi6. 1 Articolo di G. GIOVANARDI, "La Riviera Romagnola", 11 settembre 1924, da cui è tratta la citazione sopra riportata. Nell'articolo Giovanardi individua dieci contenitori con lettere dell'alfabeto, da lui riordinati in questo modo: Busta A, Busta B, Busta C, contenenti le Vite d'insigni italiani di Carlo Tonini; Busta E con Epigrafi di Luigi e Carlo Tonini; Busta F Lavori di storia patri inediti di Luigi Tonini (tali Lavori sono numerati da I a XIV; i numeri XIII e XIV rimandano a volumi mss.
    [Show full text]
  • Decoration of HELLENISTIC and ROMAN BUILDINGS in CYPRUS
    Nea Paphos Polish excavations of residential quarter of the ancient city International Conference dECORATION OF HELLENISTIC AND ROMAN BUILDINGS IN CYPRUS book of abstracts Fundacja Artibus Polish Centre of Mundi Mediterranean Archaeology Ministry of Science and Higher Education Conference financed by Minister of Science and Higher Education, agreement no. 660/P.- DUN/2016 Republic of Poland Nea Paphos Polish excavations of residential quarter of the ancient city Decoration of Hellenistic and Roman buildings in Cyprus Residences at Nea Paphos and other cities of the region International Conference Book of Abstracts Warsaw Nowy Świat 72 St. (Staszic Palace) Maria Skłodowska-Curie Hall 10 - 11 March 2017 l mission ca 0f gi o l U o n e i a v e h r c s r i t A y h o s i f l w o a P r s a w N s ea papho Warszawa, 2017 Decoration of Hellenistic and Roman buildings in Cyprus Residences at Nea Paphos and other cities of the region International Conference Warsaw, 10 - 11 March 2017 Cover design Monika Więch Cover photo Maciej Jawornicki Organizing committee Barbara Lichocka Henryk Meyza Tomasz Waliszewski Monika Więch Partners and sponsors The Polish Centre of Mediterranean Archaeology of the University of Warsaw "Artibus Mundi" Foundation Minister of Science and Higher Education Contents Henryk Meyza 5 Poverty and richness of Paphian residences problems of reconstruction of décor in structures excavated by the Polish Mission Demetrios Michaelides 7 The House of Orpheus, Nea Paphos Claire Balandier, Ségolène de Pontbriand 9 Espaces et décors d'une
    [Show full text]
  • Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: a New Weapon for Squamous Cell Carcinoma of the Head and Neck?
    cancers Communication Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck? Francesco Longo 1 , Francesco Perri 2,* , Francesco Caponigro 2, Giuseppina Della Vittoria Scarpati 3, Agostino Guida 4 , Ettore Pavone 4, Corrado Aversa 4, Paolo Muto 5, Mario Giuliano 6, Franco Ionna 4 and Raffaele Solla 7 1 Department of Otolaryngology Surgery and Oncology, Ospedale Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; [email protected] 2 Head and Neck Medical Oncology Unit, INT IRCCS Fondazione G. Pascale, 80131 Naples, Italy; [email protected] 3 Medical Oncology Unit, Hospital of Pollena Trocchia, ASLNA3 sud, 80040 Naples, Italy; [email protected] 4 Department of Otolaryngology Surgery and Oncology, INT IRCCS Fondazione G. Pascale, 80131 Naples, Italy; [email protected] (A.G.); [email protected] (E.P.); [email protected] (C.A.); [email protected] (F.I.) 5 Department of Radiation Oncology, INT IRCCS Fondazione G. Pascale, 80131 Naples, Italy; [email protected] 6 Department of Experimental and Clinical Oncology, University of Naples “Federico II”, 80131 Naples, Italy; [email protected] 7 Italian National Research Council, Institute of Biostructure & Bioimaging, 80131 Naples, Italy; raff[email protected] * Correspondence: [email protected]; Tel.: +0039-0815903362 Received: 19 August 2020; Accepted: 23 September 2020; Published: 28 September 2020 Simple Summary: Squamous cell carcinoma of the head and neck (SCCHN) represents a problem of utmost concern and, for many clinicians and surgeons, an enormous challenge.
    [Show full text]
  • Retirados Contratação Inicial E Reserva De Recrutamento
    CONCURSO DE DOCENTES ANO ESCOLAR DE 2018/2019 LISTA DEFINITIVA DE RETIRADOS CONTRATAÇÃO INICIAL E RESERVA DE RECRUTAMENTO NECESSIDADES TEMPORÁRIAS 30-08-2018 Página 1 de 106 Lista definitiva de retirados Contratação Inicial e Reserva de Recrutamento Ano Escolar de 2018/2019 Tipo de N.º de utilizador Nome Candidato(a) Motivo 6098369844 ABEL JOSÉ FEITEIRA PINHEIRO AREZ EXT Sem Preferências 6170015373 ADALBERTO DE JESUS RODRIGUES ABREU EXT Sem Preferências 7749452931 ADELAIDE MARIA DIAS GRADIM EXT Sem Preferências 6454952754 ADÉLIA PATRICIA LOPES SOARES PINTO PAIVA EXT Sem Preferências 2702383084 ADÍLIA GONÇALVES DE SOUSA MAGALHÃES EXT Sem Preferências 1710041870 ADRIANA DA CONCEIÇÃO COSTA FERREIRA FILIPE EXT Sem Preferências 6012489838 ADRIANA DE JESUS GOMES AUGUSTO EXT Sem Preferências 5362741152 ADRIANA FILIPA BARBOSA MONTEIRO EXT Sem Preferências 6006496666 ADRIANA FILIPA MOREIRA DA SILVA EXT Sem Preferências 9515613434 ADRIANA MARGARIDA MOREIRA DA ROCHA EXT Sem Preferências 7004227952 ADRIANA MARIA LEITE DA SILVA EXT Sem Preferências 3108641549 ADRIANA MARIA MOTA RAMOS EXT Sem Preferências 1033256714 ADRIANA MARISA DE BARROS BASÍLIO SILVA EXT Sem Preferências 4484813572 ADRIANA MARQUES PEIXOTO EXT Sem Preferências 5989599102 ADRIANA MATIAS PEREIRA FERREIRA EXT Sem Preferências 1427297681 ADRIANA MOREIRA LOPES DOS SANTOS SILVA EXT Sem Preferências 6345549509 ADRIANA PADILHA DA ROSA RAMOS EXT Sem Preferências 9703994989 ADRIANA RAQUEL DA SILVA FERREIRA EXT Sem Preferências 9947465535 ADRIANA SOFIA FERREIRA OLIVEIRA EXT Sem Preferências
    [Show full text]
  • Education in the EU: Diverging Learning Opportunities?
    Education in the EU: Diverging Learning Opportunities? An analysis of a decade and a half of skills using the Programme for International Student Assessment (PISA) in the European Union Background to “Growing United: Upgrading Europe’s Convergence Machine” Katia Herrera-Sosa, Margo Hoftijzer, Lucas Gortazar, & Miguel Ruiz Acknowledgments and Notes This report was prepared by Katia Herrera-Sosa, Margo Hoftijzer, Lucas Gortazar, Miguel Ruiz with Karina Acevedo and Micheline Frias. The report served as background paper for the study report, “Growing United: Reigniting Europe’s Convergence Machine,” led by Cristobal Ridao and Christian Bodewig. Contributors to the country case studies on education equity include Hanna Alasuutari (World Bank) and Jouni Välijärvi (University of Jyväskylä) for Finland; Emer Smith (Economic and Social Research Institute), Flora Kelmendi (World Bank), and Hanna Alasuutari (World Bank) for Ireland; Inge de Wolf (Maastricht University) for Netherlands; Maciek Jakubowski, Jerzy Wiśniewski (University of Warsaw), and Katia Herrera-Sosa (World Bank) for Poland, and Octavio Medina (World Bank) for Spain. Additional support was provided by Subhashini Rajasekaran, Martin Moreno, and Marc De Francis. Insightful comments were received by Juan Manuel Moreno (World Bank) at all stages of this report. For ease of reference, this report organizes EU countries into 6 regional sub-groups according to history and geography: EU17 South (Italy, Spain, Portugal, Greece, Cyprus and Malta); EU17 Continental (Luxemburg, Belgium, Austria, Netherlands, Germany and France); EU17 North (Ireland, Denmark, Finland, UK, and Sweden); CEE South (Romania and Bulgaria); CEE Continental (Slovenia, Slovakia, Hungary, Czech Republic, Poland and Croatia); CEE North (Estonia, Latvia and Lithuania). ii Contents LIST OF COUNTRIES .........................................................................................................
    [Show full text]
  • Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats
    RESEARCH ARTICLE Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats Luca Antonioli1., Maria Cecilia Giron2., Rocchina Colucci1*, Carolina Pellegrini1, Deborah Sacco1, Valentina Caputi2, Genny Orso3, Marco Tuccori1, Carmelo Scarpignato4, Corrado Blandizzi1, Matteo Fornai1 1. Division of Pharmacology and Chemotherapy, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy, 3. Scientific Institute IRCCS Eugenio Medea, Conegliano, Treviso, Italy, 4. Laboratory of Clinical Pharmacology, University of Parma, Parma, Italy *[email protected] OPEN ACCESS . These authors contributed equally to this work. Citation: Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, et al. (2014) Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats. PLoS ONE 9(12): e116253. doi:10.1371/ Abstract journal.pone.0116253 Editor: Jean Kanellopoulos, University Paris Sud, Background and Purpose: Recent evidence indicates an involvement of P2X7 France purinergic receptor (P2X7R) in the fine tuning of immune functions, as well as in Received: July 10, 2014 driving enteric neuron apoptosis under intestinal inflammation. However, the Accepted: December 6, 2014 participation of this receptor in the regulation of enteric neuromuscular functions Published: December 30, 2014 remains undetermined. This study was aimed at investigating the role of P2X7Rs in Copyright: ß 2014 Antonioli et al. This is an the control of colonic motility in experimental colitis. open-access article distributed under the terms of the Creative Commons Attribution License, which Experimental Approach: Colitis was induced in rats by 2,4-dinitrobenzenesulfonic permits unrestricted use, distribution, and repro- acid.
    [Show full text]
  • Champaign | Fall 2012 Dean's List | Illinois, out of State, International Students
    University of Illinois at Urbana-Champaign | Fall 2012 Dean's List | Illinois, Out of State, International Students STATE / ZIP MIDDLE STUDENT NATION CITY CODE FIRST NAME NAME LAST NAME CLASS COLLEGE MAJOR Illinois Students Agricultural, Consumer & IL Addison Sarah Elizabeth Adams 4 Environmental Sciences Animal Sciences IL Addison Kimberly A Arquines 3 Liberal Arts & Sciences Sociology IL Addison Alex Baciu 1 Liberal Arts & Sciences Chemical Engineering IL Addison Justin T Cruce 2 Engineering Civil Engineering IL Addison Christopher M Gerth 3 Engineering Electrical Engineering IL Addison Cheryl A Kamide 1 Division of General Studies Undeclared IL Addison Timothy P O'Connor 2 Liberal Arts & Sciences Political Science IL Addison Megh J Patel 2 Liberal Arts & Sciences Molecular and Cellular Biology IL Addison Jennifer Marie Rowley 3 Liberal Arts & Sciences English IL Addison Justin T Sumait 1 Division of General Studies Undeclared IL Algonquin Melissa Kelly Blunk 4 Applied Health Sciences Recreation, Sport, and Tourism IL Algonquin Connor Lawrence Booker 1 Liberal Arts & Sciences Biology IL Algonquin Nicholas P Demetriou 2 Engineering Materials Science & Engineering IL Algonquin Anthony J Dombrowski 4 Fine & Applied Arts Architectural Studies IL Algonquin Jessica Ann Gardeck 3 Liberal Arts & Sciences Communication IL Algonquin Jason Mark Gatz 3 Applied Health Sciences Recreation, Sport, and Tourism IL Algonquin Carol Ann Henning 4 Liberal Arts & Sciences Psychology IL Algonquin Michael E Hubner 1 Engineering Mechanical Engineering IL Algonquin
    [Show full text]
  • Archaeology and Classics
    CHICAGO, ILLINOIS JANUARY 2 – 5, 2014 WELCOME TO CHICAGO! Dear AIA Members and Colleagues, Welcome to Chicago for the 115th Annual Meeting of the Archaeological Institute of America. This year’s meeting combines an exciting program presenting cutting-edge research with the unique opportunity to socialize, network, and relax with thousands of your peers from the US, Canada, and more than 30 foreign countries. Appropriately for an urban venue settled in the 19th century by ethnic Europeans, this year’s meeting will feature several sessions on East European archaeology. And sessions devoted to heritage and preservation and digital methodologies in archaeology touch upon increasingly central concerns in the discipline. Back by popular demand are the undergraduate paper session and the Lightning Session. We are indebted to Trustee Michael L. Galaty and the Program for the Annual Meeting Committee that he chairs for fashioning such a stimulating program. Table of Contents Some of the other highlights of this year’s meeting include: General Information ......4-5 Opening Night Lecture and Reception (Thursday, 6:00–9:00 pm) Program-at-a-Glance 10-11 We kick off the meeting with a public lecture by Dr. Garrett Fagan, Professor of Ancient History at Penn State University. In “How to Stage a Bloodbath: Theatricality and Artificiality at the Roman Arena” Fagan explores Exhibitors .................. 12-13 the theatrical aspects of Roman arena games – the stage sets, equipment of the fighters, etc–that created an artificial landscape in which the violence of the spectacle was staged. Fagan will also consider what these Thursday, January 2 features tell us about Roman attitudes toward the violence of the games, and how spectators reacted to them Day-at-a-Glance ..........14 psychologically (Thursday, 6 pm).
    [Show full text]
  • Wake Forest Comprehensive Cancer Center Annual Report 2014
    2014 CANCER PROGRAM ANNUAL REPORT WITH 2013 STATISTICS TABLE OF CONTENTS 1 MESSAGE FROM THE DIRECTOR 2 CANCER REGISTRY 4 CANCER COMMITTEE MEMBERS/ CANCER REGISTRY STAFF 5 CANCER ACTIVITIES 23 CANCER DATA 29 PUBLISHED ABSTRACTS Giant Cell Carcinoma Courtesy of Dr. A. Julian Garvin, Department of Pathology 2014 1 CANCER PROGRAM ANNUAL REPORT ANNUAL PROGRAM CANCER Comprehensive Cancer Center AT WAKE FOREST BAPTIST MEDICAL CENTER “ We are extremely proud of the achievements of our Comprehensive Cancer Center as we strive to deliver the best care possible to our patients, their families and caregivers.” – Boris Pasche, MD, PhD, FACP Director, Comprehensive Cancer Center The Comprehensive Cancer Center The Cancer Center recognizes the existing floors, which house all at Wake Forest Baptist Medical the importance of building cross- outpatient oncology services as well Center was founded in the early departmental and transdisciplinary clinical trial staff. This new building 1960s and became a National Cancer team approaches to advance the provides an exceptional environment Institute-designated cancer center science and treatment of cancer. for patients, family and caregiver in 1974, shortly after the National Teams have been developed in cancer experience. Cutting-edge research Cancer Act was placed into law. genomics, tumor microenvironment, and precision medicine is available The Cancer Center received an NCI nanotechnology, imaging, novel to all patients, who have access to “comprehensive” designation in 1990. anticancer drugs, novel anticancer approximately 200 clinical trials. It is one of the longest-standing NCI devices, cancer survivorship, tobacco The Cancer Center was founded with centers, and we are proud to be a part control and cancer health disparities.
    [Show full text]